Table 2.

Adiponectin (Acrp30) levels strongly increase in common variable immunodeficiency (CVID) naïve patients but not patients with CIDP after Ig replacement therapy.

Time (days)
Parameters	0	1	7	14	21	p-Value
Acrp30 in CVID naïve patients (μg/ml)	10.96 ± 7.63	23.11 ± 6.82	21.82 ± 3.56	20.14 ± 2.65	17.65 ± 4.34	0.003
IgG in CVID naïve patients (g/l)	2.79 ± 1.98	8.79 ± 2.02	6.50 ± 1.65	6.49 ± 1.89	5.37 ± 2.32	0.000003
Acrp30 (μg/ml) in CIDP	15.28 ± 1.48	17.27 ± 0.32	17.28 ± 0.29	nd	nd	>0.05
IgG (g/l) in CIDP	11.75 ± 1.94	23.66 ± 2.36	17.705 ± 4.21	nd	nd	0.004

Data given are mean ± SD of eight CVID naïve patients and five patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

p-Value is obtained by one-way repeated measures analysis of variance with Greenhouse–Geisser corrections.